CA
LJPC

Calton & Associates’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Calton & Associates’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,800
Closed -$100K – 361
2019
Q2 		$100K Buy
+10,800
New +$81.4K 0.03% 277
2018
Q3 		– Sell
-7,900
Closed -$259K – 323
2018
Q2 		$259K Hold
7,900
– – 0.08% 218
2018
Q1 		$235K Hold
7,900
– – 0.07% 291
2017
Q4 		$266K Buy
+7,900
New +$258K 0.07% 276

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Calton & Associates's LJPC Position: Q3 2019 in Review

Calton & Associates sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2019, closing a stake of 10,800 shares — an estimated $100K sold.

Calton & Associates first reported a position in LJPC in Q4 2017 and held it in 4 quarters. The position peaked at $266K in Q4 2017. 75 funds tracked by Wall St. Rank hold LJPC as of Q3 2019.

  • Calton & Associates reported no remaining La Jolla Pharmaceutical Company position as of Q3 2019 after selling out during the quarter.
  • Calton & Associates sold 10,800 La Jolla Pharmaceutical Company shares in Q3 2019, an estimated $100K.
  • Calton & Associates first reported a position in La Jolla Pharmaceutical Company in Q4 2017 and held it in 4 quarters.
  • Calton & Associates's La Jolla Pharmaceutical Company position peaked at $266K in Q4 2017.
  • 75 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2019.

Based on Calton & Associates's 13F filing for Q3 2019, filed 7 Nov 2019.